ORLANDO, FL USA (UroToday.com) - Multiparametic MRI (mp-MRI) provides reliable evaluation of focal areas and local staging of prostate cancer. It specifically shows extracapsular extension and seminal vesicle invasion. Francesco Porpiglia and colleagues wanted to evaluate the ability of this MRI method in identifying prostatic capsular invasion (PCI) by comparing it with histopathologic evaluation.

ORLANDO, FL USA (UroToday.com) - The association between the extent of pelvic lymph node dissection (PLND) and patient survival remains still unclear in prostate cancer.

ORLANDO, FL USA (UroToday.com) - Uric acid (UA), and its physiological relevant anion urate, represent the final breakdown products of the purine degradation pathway in humans.

ORLANDO, FL USA (UroToday.com) - Dr. Armin Soave presented some very interesting data regarding the presence of circulating tumor cells (CTCs) in patients undergoing radical cystectomy (RC) for bladder cancer. The premise of the study is that presence of CTCs is a harbinger of poorer oncologic outcomes and might be an indication for chemotherapy after radical cystectomy (RC).

ORLANDO, FL USA (UroToday.com) - In this poster, Dr. Michael Gorin presented quality of life outcomes from the Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) registry. This goal of the registry is to assess the safety of active surveillance (AS) for small renal masses, 4cm or smaller, and currently includes 454 patients – 188 AS patients, 265 patients undergoing primary intervention and 21 patients crossing over from AS to intervention.

ORLANDO, FL USA (UroToday.com) - Presented by Jeffrey J Tomaszewski,¹ Renjian Jiang,² Kevin Ward,² Robert G. Uzzo,¹ and Daniel Canter³ at the American Urological Association (AUA) Annual Meeting- May 16 - 21, 2014 - Orlando, Florida USA

ORLANDO, FL USA (UroToday.com) - Management of renal masses involves extirpative treatment, ablation, and active surveillance. Nishant Patel and colleagues examined national trends in the management of renal masses, specifically those with benign histology.

ORLANDO, FL USA (UroToday.com) - Prostate specific antigen (PSA) lacks many qualities of an ideal testing marker.

ORLANDO, FL USA (UroToday.com) - Concerns regarding potential over-diagnosis and over-treatment of low-risk prostate cancer have been raised in recent years.

ORLANDO, FL USA (UroToday.com) - Men with low-risk prostate cancer are increasingly offered the option of active surveillance, involving serial prostate biopsy in order to assess for progression of disease.